Canada markets close in 5 hours 59 minutes

Datametrex AI Limited (DTMXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.15650.0000 (0.00%)
As of 2:21PM EDT. Market open.
Sign in to post a message.
  • L
    Lucky G
    Datametrex AI earned its reputation in the AI field when its analytical engine was chosen to assist military and intelligence organizations in their cybersecurity efforts. The tech has been put to use battling social media disinformation campaigns, which are designed to inflame social divisiveness, mislead voters and influence elections. It’s military-grade technology has been in use with the Canadian, US, and NATO cybersecurity forces for the past five years. The company’s core AI technology can also be modified and adapted for use in a variety of industries.

    What caught our attention is that, for a junior company, Datametrex is generating significant revenues from its operations. It recorded record revenue of $12.4 million in 2020, a 264% increase from 2019, with $8.2 million generated by Covid-19 testing kits.

    Despite the impact of the pandemic, 2020 revenues from the AI and Tech division increased to $4.1 million, up from $3.4 million in 2019. Datametrex followed that up with record revenue of $19 million in Q1 of 2021, a 2,253% increase over Q1 2020, with net earnings of $9.6 million.

    The company as a result is now cash-flow positive and has a very strong debt-free balance sheet, with over $4.6 million in cash and $4.9 million in marketable securities. This puts the firm in a very strong financial position, enabling it to consider strategies to further accelerate growth and build shareholder value.

    Datametrex’s fortunes were unexpectedly enhanced in 2020 when it was able to source diagnostic testing kits via contacts overseas. The kits were proven to be effective for detecting the Covid-19 coronavirus, which quickly became a global pandemic and turned the global economy upside down. In a massive effort to curb the spread of the virus, governments everywhere turned to testing for the virus and procured testing kits from many suppliers.

    Datametrex test kits, which have been proven to be effective in detecting the newer and more virulent variants, have been approved by multiple health regulatory agencies and the Company can sell its kits almost anywhere in the world. On July 8, 2021, Datametrex announced that it conducted approximately 62,000 COVID-19 tests for the Canadian film and production industry and sold over 50,000 of its 1Copy PCR test kits during the second quarter.

    Elsewhere, on June 21, 2021, Datametrex announced the completion of its strategic acquisition of Medi-Call, a private British Columbia telemedicine company. Telemedicine is a rapidly growing segment of the healthcare industry, enabling physicians to connect with patients via telephone or video conferencing to conduct routine consultations, patient screening, and preliminary diagnostics. This type of service is of great benefit in rural, isolated or remote areas where transportation can be difficult and very time-consuming.

    Medi-Call is a fully-integrated mobile platform that offers on-demand medical services via geo-located physicians in real-time, which allows for online, encrypted and virtually-enabled medical consultations. For patients, the online system enables real-time tracking of the progress of their health care provider, and for physicians, it enables follow-up diagnostics, clinical deterioration, and re-assessments in real time, which should lead to faster and better health outcomes. Datametrex will integrate its AI technology into the Medi-Call platform to further enhance the diagnostic capabilities and services that the system provides.

    The Covid-19 pandemic underscored the need for telemedicine due to lockdowns and restrictions on doctor and hospital visits. The pandemic has essentially altered the way many medical services will be delivered once the pandemic has diminished. Both patients and medical personnel have experienced the time-savings, reduced commuting and travel, reduced costs, increased efficiencies and other benefits of telehealth, and many methods of service delivery that were born of necessity during the pandemic may become the new normal going forward.

    Datametrex AI Ltd represents an unusual situation for a junior company. The company has been recording record revenues and earnings during the past year, much of that coming from sales of Covid-19 testing kits. Despite the massive global vaccination efforts to date, new variants are emerging as the virus mutates, therefore the need for Covid testing will likely continue for the next several years, which should continue to benefit Datametrex’s revenues and profitability.

    The revenues from the cybersecurity division continue to gain traction and its importance in the fight against social media disinformation efforts will only become greater. Telemedicine received a major boost in credibility and public acceptance due to the pandemic, and it is expected to become a normal, widely accepted methodology for patients to connect with their primary medical care providers.

    With 352.8 million shares outstanding and a relatively modest market capitaliza
  • L
    Lucky G
    Four NEW shows. So in addition to existing testing is still growing. Bonus!
  • T
    The Viking
    This stock needs so much more attention ... I have the same feeling I had with empower CBDT.CN ... I think this is a stock that will rise a lot in the near future...A LOT.
  • B
    BEL
    Telemedicine | Datametrex
    www.datametrex.com
  • L
    Lucky G
    Drone company acquisition is to bring video predictive AI into the mix. This was reported to be at the request of current and prospective clients with added value by incorporating it into Medi Call platform.
    “The impact of the acquisition of this AI business cannot be minimized. The demand for imaging predictive analytic reporting continues to be a large area of growth. As businesses and countries continue to work towards zero emissions and carbon neutral footprints, we believe that adding this imaging predictive AI element to our existing cybersecurity business will drive significant value for our stakeholders.”, said Marshall Gunter, Datametrex‘s Chief Executive Officer.

    Perspectum is a drone based imaging predictive analytics artificial intelligence (AI) services company, currently focusing on environmental and safety predictive analysis. Datametrex intends to expand the Perspectum platform into the Company’s core Cybersecurity business by integrating the Company’s AI with Perspectum.
  • L
    Lucky G
    The instant gratification crowd hasn't been paying attention. Marshall gave lots of info in the last discourse. He also let's us know he is taking a vacation and taking his young son camping. His first vacation in a year and a bonding trip with his son.
  • B
    Brad
    Well, so far at least, we weren't punished for signing new business. That's a positive, I guess. Long and strong here!
  • O
    Oaks
    great news for 2022
  • R
    Robert
    Been holding a long time done my DD see this in dollar land in the boy to distant future what is everyone’s view
  • p
    p
    How many share holders think this is a HUGE OPPORTUNITY for Datametrex? Someone please give me a thumbs up if you agree.
    https://reut.rs/3hNWWpS
  • J
    John
    Datametrex just needs a little time, not that much for those AI contracts to come in and we are off… you can tell we are close with volumes like today 3m +
  • G
    G
    How did she ever get to .37 ? Holding large here.
  • L
    Lucky G
    Marshall said in this week's discourse AI has picked back up. He also said he is often asked Why should someone invest in DM. His answer based on q2 info to come "upside potential".
  • C
    CP
    Sometimes companies like this need to report phenomenal earnings twice. If they can pull the same numbers from last earnings this will absolutely sky rocket! An upgrade to the tsx and an earnings call aswell and dm will go well over $1. It’s a joke that it’s trading at these levels but q2 2021 will be the one to send this flying to $2-$3
  • L
    Lucky G
    The tele med is really only 33% of the new company Original DM AI is 33% and the drone companies video AI the last and key component Gunter was keen on acquiring. This puts DM in a unique advantage over regular tele med. AI to manage the business interest and AI to analyze the patients for many factors ie: are they paying attention, are there signs of depression or stress from other factors.
  • j
    jiroen
    Half of Datametrex's loss in value is caused by Graph Blockchain.
    Graphblockchain's market cap has fallen from 83M to 8M between February and today: Loss of 75M
    Datametrex owns 25% of Graph, which is about 19M.
    Datametrex's market cap fell from 95M to 58M between February and today: Loss of 37M.
    19M/37M=51%
  • T
    Tommy
    This week discord with Marshall. Very promising. https://youtu.be/ptuFnSm6M6I
  • m
    mathieu
    There’s no secrets here, we need new AI contracts to get the attention of new investors. Covid revenues will help in setting up the cash position for a while, but AI revenue is what will get new money in. Let’s hope something is brewing behind the scene.
  • G
    G
    Big purchase late today . Over 300000 shares. Somebody wants in on the party .